Search

Your search keyword '"D. Alterio"' showing total 210 results

Search Constraints

Start Over You searched for: Author "D. Alterio" Remove constraint Author: "D. Alterio"
210 results on '"D. Alterio"'

Search Results

51. [Prevalence of hyperkinetic arrhythmias in a healthy infantile and adolescent population: correlations between standard ECG, stress test and dynamic ECG]

53. Exercise-induced arrhythmias: angiographic correlation and follow-up

54. 10-year survival after myocardial infarction. Longitudinal study of a hospital population

55. [Long-term (10 years) predictive value of the exercise test after myocardial infarct and significance of the longitudinal repetition of the test during follow-up]

56. 10-year follow-up of patients with intraventricular conduction defects associated with myocardial infarction: the meaning of QRS duration

57. [The exercise test in children. Study of 300 normal cases]

59. Serum Level of KL-6 as a Marker of Interstitial Lung Disease in Patients with Juvenile Systemic Sclerosis

63. EP-1085: EGFR expression in head and neck cancer : does it have a role as prognostic factor in radiotherapy?

64. High CXCR4 Expression Correlates with Sunitinib Poor Response in Metastatic Renal Cancer

65. The emerging role of Artificial Intelligence in proton therapy: A review.

66. A Transcriptomic Analysis of Laryngeal Dysplasia.

67. The prognostic role of MRI-based radiomics in tongue carcinoma: a multicentric validation study.

68. Dosimetric and NTCP analyses for selecting parotid gland cancer patients for proton therapy.

69. Salvage transoral robotic surgery in recurrent oropharyngeal carcinoma: a single-center retrospective study.

70. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis.

71. 3D-printed boluses for radiotherapy: influence of geometrical and printing parameters on dosimetric characterization and air gap evaluation.

72. Post-operative intensity-modulated vs 3D conformal radiotherapy after conservative surgery for laryngeal tumours of the supraglottic region: a dosimetric analysis on 20 patients.

73. Mapping the research landscape of HPV-positive oropharyngeal cancer: a bibliometric analysis.

74. A multicenter high-quality data registry for advanced proton therapy approaches: the POWER registry.

75. Outcomes of mini-invasive transoral surgery without neck dissection in supraglottic laryngeal cancer: Real world data from a tertiary cancer center.

76. Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach-part I: prognostic factors and indications to treatment.

77. Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers.

78. Oral Surgery and Osteoradionecrosis in Patients Undergoing Head and Neck Radiation Therapy: An Update of the Current Literature.

79. More than Five Decades of Proton Therapy: A Bibliometric Overview of the Scientific Literature.

80. Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature.

81. Can Ki-67 predict radiotherapy response in neuroendocrine tumors? Retrospective analysis of a monocentric series of patients.

82. Patients' needs in proton therapy: A survey among ten European facilities.

83. Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach, part II: radiation technique and fractionations.

84. Image-guided radiotherapy (IGRT) in Lombardy, Italy: a survey by the Lombardy section of the Italian Association of Radiotherapy and Clinical Oncology (AIRO-Lombardy).

85. Treatment of loco-regional recurrence of nasopharyngeal carcinoma in a non-endemic area: oncologic outcomes, morbidity, and proposal of a prognostic nomogram.

86. The role of radiomics in tongue cancer: A new tool for prognosis prediction.

87. Blood- and Imaging-Derived Biomarkers for Oncological Outcome Modelling in Oropharyngeal Cancer: Exploring the Low-Hanging Fruit.

88. Quality of life changes over time and predictors in a large head and neck patients' cohort: secondary analysis from an Italian multi-center longitudinal, prospective, observational study-a study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group.

89. Nasopharyngeal cancer: the impact of guidelines and teaching on radiation target volume delineation.

90. VISTA H-Score Is Significantly Associated with a 5-Year DFS Rate in Oral Squamous Cell Carcinoma.

91. Prognostic Impact of Sarcopenia's Occurrence during Radiotherapy in Oropharyngeal Cancer Patients.

92. The T-N tract involvement as a new prognostic factor for PORT in locally advanced oral cavity tumors.

93. AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC).

94. Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.

95. Upfront transoral robotic surgery (TORS) versus intensity-modulated radiation therapy (IMRT) in HPV-positive oropharyngeal cancer: real-world data from a tertiary comprehensive cancer centre.

96. Intensity-Modulated Radiotherapy (IMRT) following Conservative Surgery of the Supraglottic Region: Impact on Functional Outcomes.

97. Hypofractionated proton therapy in breast cancer: where are we? A critical review of the literature.

98. Indication to post-operative radiotherapy for oral cavity squamous cell carcinoma: what's new in the depth of infiltration (DOI) era?

99. COVID-19 and radiotherapy: impact on work and personal life of Lombardy residents during first lockdown, survey endorsed by AIRO Young.

Catalog

Books, media, physical & digital resources